Of note, given the increasingly recognized association between germline HAVCR2 aberrations and risk of HPS in patients with SPTCL, detecting HAVCR2 coding variants could aid in the early recognition of patients at increased risk for aggressive evolution of disease.10 The gene discussed is HAVCR2; the disease is subcutaneous panniculitis-like T-cell lymphoma.